Yes, Turner syndrome is a form of aneuploidy. Specifically, it is the only viable monosomy in humans, meaning a person is born with 45 chromosomes instead of the typical 46. The missing chromosome is an X chromosome, giving most affected individuals a karyotype written as 45,X. It affects roughly 1 in every 2,000 to 4,000 female live births worldwide.
What Makes Turner Syndrome an Aneuploidy
Aneuploidy means having an abnormal number of chromosomes in your cells. Most people have 23 pairs (46 total). In Turner syndrome, one of the two sex chromosomes is either completely absent or structurally incomplete, leaving the person with just 45 chromosomes. This makes it a monosomy, the specific type of aneuploidy where one chromosome from a pair is missing entirely.
Other well-known aneuploidies involve extra chromosomes. Down syndrome (trisomy 21) has three copies of chromosome 21 instead of two. Klinefelter syndrome adds an extra X chromosome (47,XXY). Turner syndrome goes in the opposite direction: it’s defined by having less genetic material than expected, not more. That distinction matters because monosomies are almost always lethal. Turner syndrome is the rare exception where a missing chromosome still allows survival, though the majority of 45,X embryos do not make it to term.
How the Missing Chromosome Happens
The underlying cause is a cell division error called nondisjunction. During the formation of egg or sperm cells, chromosomes are supposed to separate evenly. When they don’t, one reproductive cell ends up with no sex chromosome at all. If that cell is fertilized, the resulting embryo has only a single X chromosome. About 60 to 75% of the time, the error occurs during the father’s sperm production, meaning the paternal sex chromosome is the one that goes missing.
Not every case starts in the egg or sperm. In mosaic Turner syndrome, the error happens after fertilization, during early cell division of the embryo itself. This means some cells end up with the normal 46,XX and others with 45,X. The ratio of normal to abnormal cells varies from person to person, which is why mosaic Turner syndrome often produces milder symptoms than the complete form.
Complete Versus Mosaic Forms
The classic form, where every cell in the body carries only one X chromosome, is the most common karyotype. But a significant portion of people with Turner syndrome are mosaic, carrying a mixture of cell lines. Some mosaics have cells with 46,XX alongside 45,X cells. Others may carry a cell line with a structurally altered X chromosome or even a small fragment of Y chromosome material.
Standard diagnosis relies on a blood karyotype, where 20 to 30 cells are analyzed under a microscope. This catches most cases but can miss low-level mosaicism (less than 10% of cells) because the sample size is relatively small. When mosaicism is suspected but doesn’t show up on a standard karyotype, more sensitive techniques like FISH (which uses fluorescent probes to tag specific chromosomes) can scan hundreds of cells and detect rarer cell lines, including hidden Y chromosome material that has implications for medical monitoring.
Physical and Developmental Effects
Short stature is the most consistent feature. Without treatment, adult height averages around 4 feet 8 inches. Other common physical traits include a short neck with a webbed appearance, a low hairline at the back of the head, low-set ears, and puffy hands and feet at birth. Soft fingernails that curve upward are another recognizable sign. Not everyone has all of these features, and people with mosaic forms may have very few visible signs.
Heart differences are a serious concern. Between 15% and 30% of people with Turner syndrome have a bicuspid aortic valve, where the heart’s main outflow valve has two flaps instead of three. Aortic coarctation, a narrowing of the body’s largest artery, occurs in 7% to 18%. These conditions require ongoing cardiac monitoring because they can lead to complications later in life, including aortic dilation and dissection.
Ovarian Function and Fertility
The missing X chromosome has a dramatic effect on the ovaries. Early in fetal development, the ovaries initially contain a normal number of egg cells. But without two functioning X chromosomes, those cells die off at an accelerated rate through a process of programmed cell death. By the time most girls with Turner syndrome reach puberty, the ovaries have very few or no remaining follicles. About 70 to 80% will not enter puberty on their own, and roughly 90% experience primary amenorrhea, meaning they never have a menstrual period without hormone therapy.
Women with mosaic Turner syndrome fare somewhat better. If enough of their ovarian cells carry the normal 46,XX karyotype, they may have a larger reserve of egg cells at birth, enough to go through puberty naturally and even menstruate for a time. But even these women tend to exhaust their egg supply faster than average and face premature ovarian insufficiency, often well before age 40. Fertility preservation through egg or embryo freezing is an option for some, though success rates specific to Turner syndrome are still not well established.
How Turner Syndrome Is Managed
Growth hormone therapy is the primary treatment for short stature and is typically started in childhood. It can add several inches to final adult height, though results vary depending on when treatment begins and how long it continues.
Estrogen replacement is the other cornerstone of care. For girls who don’t enter puberty spontaneously, low-dose estrogen is introduced gradually, often using skin patches that deliver the hormone in a way that closely mimics natural production. The dose is increased slowly over about three to three and a half years, guided by bone development, growth, and the progression of puberty. After roughly two and a half years on estrogen, a second hormone (a progestin) is added to protect the uterine lining. Many women with Turner syndrome continue hormone therapy into adulthood to support bone health and cardiovascular function.
Beyond hormones, ongoing monitoring for heart abnormalities, thyroid function, hearing changes, kidney differences, and metabolic health is a standard part of care throughout life. The specific mix of features varies widely from person to person, so management plans are highly individualized.
Prenatal Detection
Turner syndrome can be flagged before birth through cell-free DNA screening (commonly called NIPT), but the positive predictive value for this condition is only about 32%. That means roughly two out of three positive screening results turn out to be false alarms. A positive screen is always followed by confirmatory testing, either chorionic villus sampling or amniocentesis, which directly analyzes fetal chromosomes and gives a definitive answer. Physical signs on ultrasound, such as fluid accumulation at the back of the neck or heart defects, can also raise suspicion during pregnancy.